Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Educational Intervention on RSV Vaccine Knowledge and Acceptance in Thai Pregnant Women
TCTR20251226003Phase 0Completed
- Sponsor
- Ratchadaphiseksomphot Endowment Fund
- Start
- Dec 2025
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 0, open-label, single-arm trial of RSV vaccine in respiratory syncytial virus disease (RSV), sponsored by Ratchadaphiseksomphot Endowment Fund. Primary endpoints: Change in knowledge about RSV and RSV vaccination and Acceptance of RSV vaccine. Started Dec 2025; status: completed.
02
Drugs
RSV vaccine
03
Conditions
respiratory syncytial virus disease (RSV)
Beyond the preview
Go deeper on TCTR20251226003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20251226003.